{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:42:53Z","timestamp":1791106973853,"version":"4.1.0"},"publisher-location":"Totowa, NJ","reference-count":15,"publisher":"Humana Press","isbn-type":[{"value":"9781588299703","type":"print"},{"value":"9781597453943","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-1-59745-394-3_22","type":"book-chapter","created":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T16:59:38Z","timestamp":1251565178000},"page":"295-304","source":"Crossref","is-referenced-by-count":24,"title":["Screening of Small-Molecule Compounds as Inhibitors of HCV Entry"],"prefix":"10.1007","author":[{"given":"Jian-Ping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flossie","family":"Wong-Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1358\/dnp.2000.13.2.656262","volume":"13","author":"R.B. Perni","year":"2000","unstructured":"Perni, R. B. (2000) NS3.4A protease as a target for interfering with hepatitis C virus replication. Drug News Perspect. 13, 69\u201377.","journal-title":"Drug News Perspect."},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(03)00028-7","volume":"58","author":"R. Francesco De","year":"2003","unstructured":"De Francesco, R., Tomei, L., Altamura, S., Summa, V., and Migliaccio, G. (2003) Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res. 58, 1\u201316.","journal-title":"Antiviral Res."},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1002\/hep.21064","volume":"43","author":"J.M. Pawlotsky","year":"2006","unstructured":"Pawlotsky, J. M. (2006) Therapy of hepatitis C: from empiricism to eradication. Hepatology 43, S207\u2013S220.","journal-title":"Hepatology"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P. Pileri","year":"1998","unstructured":"Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., et al. (1998) Binding of hepatitis C virus to CD81. Science 282, 938\u2013941.","journal-title":"Science"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/JVI.72.5.3827-3836.1998","volume":"72","author":"T.F. Baumert","year":"1998","unstructured":"Baumert, T. F., Ito, S., Wong, D. T., and Liang, T. J. (1998) Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J. Virol. 72, 3827\u20133836.","journal-title":"J. Virol."},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","volume":"197","author":"B. Bartosch","year":"2003","unstructured":"Bartosch, B., Dubuisson, J., and Cosset, F. L. (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197, 633\u2013642.","journal-title":"J. Exp. Med."},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0832180100","volume":"100","author":"M. Hsu","year":"2003","unstructured":"Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., et al. (2003) Hepatitis C virus glycoproteins mediatepH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 100, 7271\u20137276.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"B.D. Lindenbach","year":"2005","unstructured":"Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309, 623\u2013626.","journal-title":"Science"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T. Wakita","year":"2005","unstructured":"Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791\u2013796.","journal-title":"Nat. Med."},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J. Zhong","year":"2005","unstructured":"Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., et al. (2005) Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102, 9294\u20139299.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"14199","DOI":"10.1073\/pnas.2335981100","volume":"100","author":"B. Bartosch","year":"2003","unstructured":"Bartosch, B., Bukh, J., Meunier, J. C., Granier, C., Engle, R. E., Blackwelder, W. C., et al. (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc. Natl. Acad. Sci. USA 100, 14199\u201314204.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1073\/pnas.0501275102","volume":"102","author":"J.C. Meunier","year":"2005","unstructured":"Meunier, J. C., Engle, R. E., Faulk, K., Zhao, M., Bartosch, B., Alter, H., et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. USA 102, 4560\u20134565.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1073\/pnas.0403519101","volume":"101","author":"C. Logvinoff","year":"2004","unstructured":"Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., et al. (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 101, 10149\u201310154.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0402253101","volume":"101","author":"E. G. Cormier","year":"2004","unstructured":"Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P., and Dragic, T. (2004) CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 101, 7270\u20137274.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"8496","DOI":"10.1128\/JVI.78.16.8496-8505.2004","volume":"78","author":"J.A. McKeating","year":"2004","unstructured":"McKeating, J. A., Zhang, L. Q., Logvinoff, C., Flint, M., Zhang, J., Yu, J., et al. (2004) Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78, 8496\u20138505.","journal-title":"J. Virol."}],"container-title":["Methods in Molecular Biology","Hepatitis C: Methods and Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T21:59:00Z","timestamp":1590098340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-59745-394-3_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9781588299703","9781597453943"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-59745-394-3_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[]}}